143 related articles for article (PubMed ID: 456969)
21. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
22. [Medical treatment of gallstones (author's transl)].
Gérolami A; Montet JC; Marteau C; Reynier MO; Crotte C
Gastroenterol Clin Biol; 1980; 4(8-9):588-99. PubMed ID: 7000610
[No Abstract] [Full Text] [Related]
23. [The clinical significance of bile acid metabolism].
Brückner B
Zentralbl Chir; 1980; 105(6):366-70. PubMed ID: 7415643
[TBL] [Abstract][Full Text] [Related]
24. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
von Bergmann K; Epple-Gutsfeld M; Leiss O
Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
[TBL] [Abstract][Full Text] [Related]
25. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
[TBL] [Abstract][Full Text] [Related]
26. Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry.
Tadano T; Kanoh M; Matsumoto M; Sakamoto K; Kamano T
Rinsho Byori; 2006 Feb; 54(2):103-10. PubMed ID: 16548228
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
[TBL] [Abstract][Full Text] [Related]
28. The clinical significance of bile reflux.
Rhodes J
Scand J Gastroenterol Suppl; 1981; 67():173-5. PubMed ID: 6941400
[TBL] [Abstract][Full Text] [Related]
29. Dissolution of gallstones with bile salts, lecithin, and heparin.
Cheung LY; Englert E; Moody FG; Wales EE
Surgery; 1974 Sep; 76(3):500-3. PubMed ID: 4851407
[No Abstract] [Full Text] [Related]
30. Gallstone dissolution in vitro by bile acids, heparin, and quanternary amines.
Lahana DA; Bonorris GG; Schoenfield LJ
Surg Gynecol Obstet; 1974 May; 138(5):683-5. PubMed ID: 4823370
[No Abstract] [Full Text] [Related]
31. Proceedings: Mechanism of action of chenodeoxycholic acid in gallstone dissolution.
Northfield TC; Larusso NF; Thistle JL; Hofmann AF
Gut; 1973 Oct; 14(10):826-7. PubMed ID: 4758693
[No Abstract] [Full Text] [Related]
32. Effect of bile salts and fatty acids on the colonic absorption of oxalate.
Dobbins JW; Binder HJ
Gastroenterology; 1976 Jun; 70(6):1096-1100. PubMed ID: 1269869
[TBL] [Abstract][Full Text] [Related]
33. [The content of cholylglycine in the blood serum in cholelithiasis during treatment with litholytic preparations of bile acids].
Bocharova LV; Genia LP; Lemeshko ZA; Petrova EA
Lab Delo; 1989; (3):59-61. PubMed ID: 2469846
[TBL] [Abstract][Full Text] [Related]
34. [The significance of the bacterial steroid degradation for the etiology of large bowel cancer. VIII. Transformation of cholic-, chenodeoxycholic-, and deoxycholic acid by lecithinase-lipase-negative clostridia].
Edenharder R; Deser HJ
Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):91-104. PubMed ID: 7324622
[TBL] [Abstract][Full Text] [Related]
35. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
[TBL] [Abstract][Full Text] [Related]
36. The fate of labelled bile salts introduced into the colon.
Morris JS; Heaton KW
Scand J Gastroenterol; 1974; 9(1):33-9. PubMed ID: 4453804
[No Abstract] [Full Text] [Related]
37. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids.
Attili AF; Angelico M; Cantafora A; Alvaro D; Capocaccia L
Med Hypotheses; 1986 Jan; 19(1):57-69. PubMed ID: 2871479
[TBL] [Abstract][Full Text] [Related]
38. [Enterohepatic circulation of bile acids and abnormalities].
Oosuga T
Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):346-9. PubMed ID: 2332688
[No Abstract] [Full Text] [Related]
39. Targeting bile acids in the treatment of constipation.
Maneerattanaporn M; Chey WD
Expert Rev Gastroenterol Hepatol; 2011 Dec; 5(6):657-9. PubMed ID: 22017692
[No Abstract] [Full Text] [Related]
40. Bile acids are not equally damaging to the gastric mucosa.
Harmon JW; Doong T; Gadacz TR
Surgery; 1978 Jul; 84(1):79-86. PubMed ID: 26987
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
